Funding for this research was provided by:
Charité
Article History
Received: 15 April 2020
Accepted: 27 April 2020
First Online: 26 May 2020
Compliance with ethical guidelines
:
: S. Rossberg, U. Pleyer and S. Lau have no direct conflict of interest regarding this article. However, outside this publication, the following conflict of interest statement can be made: S. Lau has received honoraria from Boehringer, ALK, Sanofi-Genzyme, Allergopharma, Nutricia, DBV and ALK and participated as PI and deputy in studies funded by Allergopharma, Boehringer, Aimmune and DBV. U. Pleyer has served as principal investigator or consultant for the following: Abbvie, Alcon, Allergan, Alimera, Bayer, Dompé, Lilly, Novartis, Santen, Shire, Thea, Ursapharm, Winzer.
: The off-label use was announced to the ethics committee and was approved as individual treatment decision.